Shortening the time to confirm or to rebut Adverse events of interest related to innovative Therapies for immune-mediated inflammATory dIseases: cross-talking between different data sOURces. SATURATIOn study. First published 27/06/2024 Last updated 27/06/2024 EU PAS number: EUPAS1000000207StudyPlanned